Andrew C. Emery

Andrew C. Emery

Auto-generated profile, based on publicly available information

Andrew C. Emery

Section on Molecular Neuroscience, National Institute of Mental Health (NIH), Bethesda, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
Limei ZhangLimei Zhang
Limei Zhang
VHVito S. Hernández
Vito S. Hernández
JSJerome D. Swinny
Jerome D. Swinny
AVAnil K. Verma
Anil K. Verma
TGTorsten Giesecke
Torsten Giesecke
LELee Eiden
Lee Eiden
The lateral habenula (LHb) has a key role in integrating a variety of neural circuits associated with reward and aversive behaviors. There is limited information about how the different cell types and neuronal circuits within the LHb coordinate physiological and motivational states. Here, we report a cell type in the medial division of the LHb (LHbM) in male rats that is distinguished by: (1) a molecular signature for GABAergic neurotransmission (Slc32a1/VGAT) and estrogen receptor (Esr1/ERα) expression, at both mRNA and protein levels, as well as the mRNA for vesicular glutamate transporter Slc17a6/VGLUT2, which we term the GABAergic estrogen-receptive neuron (GERN); (2) its axonal projection patterns, identified by in vivo juxtacellular labeling, to both local LHb and to midbrain modulatory systems; and (3) its somatic expression of receptors for vasopressin, serotonin and dopamine, and mRNA for orexin receptor 2. This cell type is anatomically located to receive afferents from midbrain reward (dopamine and serotonin) and hypothalamic water and energy homeostasis (vasopressin and orexin) circuits. These afferents shared the expression of estrogen synthase (aromatase) and VGLUT2, both in their somata and axon terminals. We demonstrate dynamic changes in LHbM VGAT+ cell density, dependent upon gonadal functional status, that closely correlate with motivational behavior in response to predator and forced swim stressors. The findings suggest that the homeostasis and reward-related glutamatergic convergent projecting pathways to LHbMC employ a localized neurosteroid signaling mechanism via axonal expression of aromatase, to act as a switch for GERN excitation/inhibition output prevalence, influencing depressive or motivated behavior.

24 April 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AEAndrew C. Emery
Andrew C. Emery
LELee Eiden
Lee Eiden
Both cAMP and ERK are necessary for neuroendocrine cell neuritogenesis, and pituitary adenylate cyclase‐activating polypeptide (PACAP) activates each. It is important to know whether cAMP and ERK are arranged in a novel, linear pathway or in two parallel pathways using known signaling mechanisms. Native cellular responses [cAMP elevation, ERK phosphorylation, cAMP responsive element binding (CREB) phosphorylation, and neuritogenesis] and promoter‐reporter gene activation after treatment with forskolin, cAMP analogs, and PACAP were measured in Neuroscreen‐1 (NS‐1) cells, a PC12 variant enabling simultaneous morphological, molecular biological, and biochemical analysis. Forskolin (25 μM) and cAMP analogs (8‐bromo‐cAMP, dibutyryl‐cAMP, and 8‐chlorophenylthio‐cAMP) stimulated ERK phosphorylation and neuritogenesis in NS‐1 cells. Both ERK phosphorylation and neuritogenesis were MEK dependent (blocked by 10 μM U0126) and PKA independent (insensitive to 30 μM H‐89 or 100 nM myristoylated protein kinase A inhibitor). CREB phosphorylation induced by PACAP was blocked by H‐89. The exchange protein activated by cAMP (Epac)‐selective 8‐(4‐chlorophenylthio)‐2′‐ O ‐Me‐cAMP (100–500 μM) activated Rap1 without affecting the other cAMP‐dependent processes. Thus, PACAP‐38 potently stimulated two distinct and independent cAMP pathways leading to CREB or ERK activation in NS‐1 cells. Drug concentrations for appropriate effect were derived from control data for all compounds. In summary, a novel PKA‐ and Epac‐independent signaling pathway: PACAP → adenylate cyclase → cAMP → ERK → neuritogenesis has been identified.—Emery, A. C., Eiden, L. E. Signaling through the neuropeptide GPCR PAC 1 induces neuritogenesis via a single linear cAMP‐ and ERK‐dependent pathway using a novel cAMP sensor. FASEB J. 26, 3199–3211 (2012). www.fasebj.org

25 June 2013 in Science Signaling
Verified
Journal Article
Open access
PDF file
AEAndrew C. Emery
Andrew C. Emery
MEMaribeth V. Eiden
Maribeth V. Eiden
TMTomris Mustafa
Tomris Mustafa
LELee Eiden
Lee Eiden
The guanine nucleotide exchange factor Rapgef2 links cAMP and ERK signaling to mediate neuritogenesis.

1 August 2012 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
AEAndrew C. Emery
Andrew C. Emery
JDJohn O. DiRaddo
John O. DiRaddo
EMEric Miller
Eric Miller
HHHannah A. Hathaway
Hannah A. Hathaway
SPSergey Pshenichkin
Sergey Pshenichkin
JWJarda T. Wroblewski
Jarda T. Wroblewski
The metabotropic glutamate 1a (mGlu1a) receptor is a G protein-coupled receptor linked with phosphoinositide (PI) hydrolysis and with β-arrestin-1-mediated sustained extracellular signal-regulated kinase (ERK) phosphorylation and cytoprotective signaling. Previously, we reported the existence of ligand bias at this receptor, inasmuch as glutamate induced both effects, whereas quisqualate induced only PI hydrolysis. In the current study, we showed that mGlu1 receptor agonists such as glutamate, aspartate, and l-cysteate were unbiased and activated both signaling pathways, whereas quisqualate and (S)-3,5-dihydroxyphenylglycine stimulated only PI hydrolysis. Competitive antagonists inhibited only PI hydrolysis and not the β-arrestin-dependent pathway, whereas a noncompetitive mGlu1 receptor antagonist blocked both pathways. Mutational analysis of the ligand binding domain of the mGlu1a receptor revealed that Thr188 residues were essential for PI hydrolysis but not for protective signaling, whereas Arg323 and Lys409 residues were required for β-arrestin-1-mediated sustained ERK phosphorylation and cytoprotective signaling but not for PI hydrolysis. Therefore, the mechanism of ligand bias appears to involve different modes of agonist interactions with the receptor ligand binding domain. Although some mGlu1a receptor agonists are biased toward PI hydrolysis, we identified two endogenous compounds, glutaric acid and succinic acid, as new mGlu1 receptor agonists that are fully biased toward β-arrestin-mediated protective signaling. Pharmacological studies indicated that, in producing the two effects, glutamate interacted in two distinct ways with mGlu1 receptors, inasmuch as competitive mGlu1 receptor antagonists that blocked PI hydrolysis did not inhibit cytoprotective signaling. Quisqualate, which is biased toward PI hydrolysis, failed to inhibit glutamate-induced protection, and glutaric acid, which is biased toward protection, did not interfere with glutamate-induced PI hydrolysis. Taken together, these data indicate that ligand bias at mGlu1 receptors is attributable to different modes of receptor-glutamate interactions, which are differentially coupled to PI hydrolysis and β-arrestin-mediated cytoprotective signaling, and they reveal the existence of new endogenous agonists acting at mGlu1 receptors.

30 September 2017 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
LELee Eiden
Lee Eiden
AEAndrew C. Emery
Andrew C. Emery
Limei ZhangLimei Zhang
Limei Zhang
CSCorey B. Smith
Corey B. Smith

1 August 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AEAndrew C. Emery
Andrew C. Emery
SPSergey Pshenichkin
Sergey Pshenichkin
GDGuy Rodrigue Takoudjou Dzomo
Guy Rodrigue Takoudjou Dzomo
EGEwa Grajkowska
Ewa Grajkowska
BWBarry B. Wolfe
Barry B. Wolfe
JWJarda T. Wroblewski
Jarda T. Wroblewski
Metabotropic glutamate receptor 1 (mGlu1) is a G protein-coupled receptor that enhances the hydrolysis of membrane phosphoinositides. In addition to its role in synaptic transmission and plasticity, mGlu1 has been shown to be involved in neuroprotection and neurodegeneration. In this capacity, we have reported previously that in neuronal cells, mGlu1a exhibits the properties of a dependence receptor, inducing apoptosis in the absence of glutamate, while promoting neuronal survival in its presence (Pshenichkin, S., Dolińska, M., Klauzińska, M., Luchenko, V., Grajkowska, E., and Wroblewski, J. T. (2008) Neuropharmacology 55, 500-508). Here, using CHO cells expressing mGlu1a receptors, we show that the protective effect of glutamate does not rely on the classical mGlu1 signal transduction. Instead, mGlu1a protective signaling is mediated by a novel, G protein-independent, pathway which involves the activation of the MAPK pathway and a sustained phosphorylation of ERK, which is distinct from the G protein-mediated transient ERK phosphorylation. Moreover, the sustained phosphorylation of ERK and protective signaling through mGlu1a receptors require expression of beta-arrestin-1, suggesting a possible role for receptor internalization in this process. Our data reveal the existence of a novel, noncanonical signaling pathway associated with mGlu1a receptors, which mediates glutamate-induced protective signaling.